Addus HomeCare Corporation (ADUS)
NASDAQ: ADUS · IEX Real-Time Price · USD
97.19
+0.03 (0.03%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Addus HomeCare Market Cap
Addus HomeCare has a market cap or net worth of $1.58 billion as of April 19, 2024. Its market cap has decreased by -12.86% in one year.
Market Cap
1.58B
Enterprise Value
1.69B
1-Year Change
-12.86%
Ranking
Category
Stock Price
$97.19
Market Cap Chart
Since October 28, 2009, Addus HomeCare's market cap has increased from $85.70M to $1.58B, an increase of 1,740.29%. That is a compound annual growth rate of 22.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 1.58B | 0.55% |
Apr 17, 2024 | 1.57B | -0.38% |
Apr 16, 2024 | 1.57B | 0.27% |
Apr 15, 2024 | 1.57B | -1.14% |
Apr 12, 2024 | 1.59B | -1.44% |
Apr 11, 2024 | 1.61B | 2.32% |
Apr 10, 2024 | 1.57B | -1.67% |
Apr 9, 2024 | 1.60B | -2.49% |
Apr 8, 2024 | 1.64B | -0.91% |
Apr 5, 2024 | 1.66B | -0.05% |
Apr 4, 2024 | 1.66B | -0.42% |
Apr 3, 2024 | 1.66B | 0.92% |
Apr 2, 2024 | 1.65B | -1.47% |
Apr 1, 2024 | 1.67B | -0.16% |
Mar 28, 2024 | 1.68B | -0.39% |
Mar 27, 2024 | 1.68B | 1.15% |
Mar 26, 2024 | 1.66B | -0.14% |
Mar 25, 2024 | 1.67B | -0.76% |
Mar 22, 2024 | 1.68B | 2.17% |
Mar 21, 2024 | 1.64B | 0.06% |
Mar 20, 2024 | 1.64B | 0.69% |
Mar 19, 2024 | 1.63B | -0.65% |
Mar 18, 2024 | 1.64B | 4.59% |
Mar 15, 2024 | 1.57B | -1.32% |
Mar 14, 2024 | 1.59B | -1.06% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Neumora Therapeutics | 1.63B |
Recursion Pharmaceuticals | 1.62B |
Supernus Pharmaceuticals | 1.60B |
Avadel Pharmaceuticals | 1.59B |
Taro Pharmaceutical Industries | 1.59B |
InMode | 1.51B |
Ardelyx | 1.51B |
Protagonist Therapeutics | 1.49B |